Literature DB >> 3730419

Modulation of ornithine decarboxylase activity and ornithine decarboxylase-antizyme complex in rat heart by hormone and putrescine treatment.

F Flamigni, C Stefanelli, C Guarnieri, C M Caldarera.   

Abstract

Ornithine decarboxylase was present in a cryptic, complexed form in an amount approximately equivalent to that of free ornithine decarboxylase activity in adult rat heart. Addition of isoproterenol (10 mg/kg) caused a notable rise in ornithine decarboxylase activity and a simultaneous decrease in the amount of the complexed enzyme. During the period of ornithine decarboxylase decay, when cardiac putrescine content had reached high values, the level of the complex increased above that of the control. Administration of putrescine (1.5 mmol/kg, twice) or dexamethasone (4 mg/kg) produced a decrease of heart ornithine decarboxylase activity, while it did not remarkably affect the level of complexed ornithine decarboxylase, therefore raising significantly the ratio of bound to total ornithine decarboxylase. Putrescine also elicited the appearance of free antizyme, concomitantly with the disappearance of free ornithine decarboxylase activity after 3-4 h of treatment. These results indicate that a significant amount of ornithine decarboxylase occurs in an inactive form in the heart under physiological conditions and that its absolute and relative levels may vary following stimuli which affect heart ornithine decarboxylase activity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3730419     DOI: 10.1016/0304-4165(86)90261-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Inhibition of the expression of ornithine decarboxylase and c-Myc by cell-permeant ceramide in difluoromethylornithine-resistant leukaemia cells.

Authors:  F Flamigni; I Faenza; S Marmiroli; I Stanic'; A Giaccari; C Muscari; C Stefanelli; C Rossoni
Journal:  Biochem J       Date:  1997-06-15       Impact factor: 3.857

Review 2.  Rapid and regulated degradation of ornithine decarboxylase.

Authors:  S Hayashi; Y Murakami
Journal:  Biochem J       Date:  1995-02-15       Impact factor: 3.857

3.  Properties and fluctuations in vivo of rat liver antizyme inhibitor.

Authors:  Y Murakami; S Matsufuji; M Nishiyama; S Hayashi
Journal:  Biochem J       Date:  1989-05-01       Impact factor: 3.857

4.  Rat liver cytosol contains NADPH- and GSH-dependent factors able to restore ornithine decarboxylase inactivated by removal of thiol reducing agents.

Authors:  F Flamigni; C Guarnieri; C M Caldarera
Journal:  Biochem J       Date:  1988-02-15       Impact factor: 3.857

5.  Zinc is required for the expression of ornithine decarboxylase in a difluoromethylornithine-resistant cell line.

Authors:  F Flamigni; G Campana; L Carboni; C Guarnieri; S Spampinato
Journal:  Biochem J       Date:  1994-04-15       Impact factor: 3.857

6.  Zinc can influence ornithine decarboxylase activity in rat thymus cells.

Authors:  C Stefanelli; F Ferrari; C Rossoni; F Flamigni; C M Caldarera
Journal:  Amino Acids       Date:  1993-02       Impact factor: 3.520

7.  Ornithine decarboxylase antizyme in kidneys of male and female mice.

Authors:  Y Murakami; M Marumo; S Hayashi
Journal:  Biochem J       Date:  1988-09-01       Impact factor: 3.857

8.  Correlation between endogenous polyamines in human cardiac tissues and clinical parameters in patients with heart failure.

Authors:  Clara Meana; José Manuel Rubín; Carmen Bordallo; Lorena Suárez; Javier Bordallo; Manuel Sánchez
Journal:  J Cell Mol Med       Date:  2015-11-18       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.